These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1127 related items for PubMed ID: 23674658

  • 1. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [Abstract] [Full Text] [Related]

  • 2. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, Matsuo K, Yokoi K.
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [Abstract] [Full Text] [Related]

  • 3. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
    Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, Tokunaga T, Apolone G, Margaritora S, Granone P.
    Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
    [Abstract] [Full Text] [Related]

  • 4. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M.
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
    Kaira K, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Shukuya T, Kenmotsu H, Naito T, Hayashi I, Oriuchi N, Endo M, Kondo H, Nakajima T, Yamamoto N.
    Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
    [Abstract] [Full Text] [Related]

  • 6. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
    Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Tsuya A, Nakamura Y, Naito T, Hayashi I, Serizawa M, Koh Y, Hanaoka H, Tominaga H, Oriuchi N, Kondo H, Nakajima T, Yamamoto N.
    J Clin Oncol; 2010 Aug 10; 28(23):3746-53. PubMed ID: 20625125
    [Abstract] [Full Text] [Related]

  • 7. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
    Yamada T, Uchida M, Kwang-Lee K, Kitamura N, Yoshimura T, Sasabe E, Yamamoto T.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr 10; 113(4):464-71. PubMed ID: 22676927
    [Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
    Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA.
    J Nucl Med; 2006 Oct 10; 47(10):1628-34. PubMed ID: 17015898
    [Abstract] [Full Text] [Related]

  • 9. Tumor immunity is related to 18 F-FDG uptake in thymic epithelial tumor.
    Imai H, Kaira K, Hashimoto K, Nitanda H, Taguchi R, Yanagihara A, Umesaki T, Yamaguchi O, Mouri A, Kawasaki T, Yasuda M, Kobayashi K, Sakaguchi H, Kuji I, Kagamu H.
    Cancer Med; 2021 Sep 10; 10(18):6317-6326. PubMed ID: 34363337
    [Abstract] [Full Text] [Related]

  • 10. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M.
    Ann Nucl Med; 2014 Apr 10; 28(3):257-62. PubMed ID: 24430867
    [Abstract] [Full Text] [Related]

  • 11. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
    Eguchi T, Yoshida K, Hamanaka K, Shiina T, Koizumi T, Kawakami S, Oguchi K, Amano J.
    Eur J Cardiothorac Surg; 2012 May 10; 41(5):1059-62. PubMed ID: 22219437
    [Abstract] [Full Text] [Related]

  • 12. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
    Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F.
    Lung Cancer; 2014 Oct 10; 86(1):5-13. PubMed ID: 25175317
    [Abstract] [Full Text] [Related]

  • 13. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
    Xu H, Li B, Yu W, Wang H, Zhao X, Yao Y, Huang D.
    Nucl Med Commun; 2013 Oct 10; 34(10):953-8. PubMed ID: 23887273
    [Abstract] [Full Text] [Related]

  • 14. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF, Zhao X, Zhou SH, Lu ZJ, Zhao K, Fan J, Zhou ML.
    Oncotarget; 2017 May 23; 8(21):34709-34726. PubMed ID: 28410229
    [Abstract] [Full Text] [Related]

  • 15. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
    Zhao J, Wang H, Li Q.
    Nucl Med Commun; 2020 Apr 23; 41(4):405-410. PubMed ID: 32032191
    [Abstract] [Full Text] [Related]

  • 16. Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
    Choi WH, Yoo IeR, O JH, Kim TJ, Lee KY, Kim YK.
    Technol Health Care; 2015 Apr 23; 23 Suppl 2():S311-8. PubMed ID: 26410497
    [Abstract] [Full Text] [Related]

  • 17. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
    Park SY, Cho A, Bae MK, Lee CY, Kim DJ, Chung KY.
    Clin Nucl Med; 2016 Jan 23; 41(1):15-20. PubMed ID: 26545017
    [Abstract] [Full Text] [Related]

  • 18. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
    De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S.
    Clin Nucl Med; 2013 May 23; 38(5):354-8. PubMed ID: 23486323
    [Abstract] [Full Text] [Related]

  • 19. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
    Yabuuchi H, Matsuo Y, Abe K, Baba S, Sunami S, Kamitani T, Yonezawa M, Yamasaki Y, Kawanami S, Nagao M, Okamoto T, Nakamura K, Yamamoto H, Sasaki M, Honda H.
    Clin Radiol; 2015 Nov 23; 70(11):1289-98. PubMed ID: 26272529
    [Abstract] [Full Text] [Related]

  • 20. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
    Tomita M, Ayabe T, Tsuchiya K, Nakamura K.
    Thorac Cardiovasc Surg; 2018 Jun 23; 66(4):345-349. PubMed ID: 28728209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.